CHRONOS-3: Randomized Phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolent non-Hodgkin lymphoma (iNHL) Meeting Abstract
| Authors: | Matasar, M. J.; Capra, M.; Özcan, M.; Lv, F.; Li, W.; Yañez, E.; Sapunarova, K.; Lin, T.; Jin, J.; Jurczak, W.; Hamed, A.; Wang, M. C.; Baker, R.; Bondarenko, I.; Zhang, Q.; Feng, J.; Geissler, K.; Lazaroiu, M.; Saydam, G.; Szomor, A.; Bouabdallah, K.; Galiulin, R.; Uchida, T.; Soler, L. M.; Cao, A.; Hiemeyer, F.; Mehra, A.; Childs, B. H.; Shi, Y.; Zinzani, P. L. |
| Abstract Title: | CHRONOS-3: Randomized Phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolent non-Hodgkin lymphoma (iNHL) |
| Meeting Title: | 112th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 81 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2021 Apr 10-15/May 17-21 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2021-07-01 |
| Language: | English |
| ACCESSION: | WOS:000680263501025 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.AM2021-CT001 |
| Notes: | Meeting Abstract: CT001 -- Due to Covid 19 pandemic, the conference was held virtually -- Source: Wos |
